M&C Life Science Co., Ltd. (XKON:A225860) announced a private placement of 6th series non-guaranteed private placement convertible bonds for gross proceeds of KRW 600,000,000 on June 22, 2021. The transaction will include participation from New Life Group Corporation. The bonds will have interest rate of 1% and yield to maturity of 3%. The bonds will mature on June 25, 2024. The bonds will be fully convertible into 6,000,000 shares of the company at a fixed conversion price of KRW 100 between the period of June 25, 2022 to June 24, 2024. The transaction has been approved by the board of directors of the company. The payment date is June 25, 2021.